Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.
Chowdhury T, Tesileanu CMS, Kocakavuk E, Johnson KC, Lee J, Erson-Omay Z, Heo C, Aldape K, Amin SB, Anderson KJ, Ashley DM, Barnholtz-Sloan JS, Brat DJ, Brodbelt AR, Castro AV, Claus EB, Connelly JM, Costello J, Datta I, Elliott C, Finocchiaro G, French PJ, Gan HK, Garofano L, Ghospurkar PL, Golebiewska A, Gundla PS, Hermes B, Hong C, Hoogstrate Y, Horbinski C, Huse JT, Iavarone A, Karadag C, Khasraw M, Kouwenhoven MC, LaViolette PS, Li K, Lowman A, McCortney K, Moon HE, Nader S, Nasrallah MP, Ng HK, Ormond DR, Padovan M, Paek SH, Poisson LM, Puri S, Shen E, Shwetal M, Sloan AE, Vallentgoed WR, Van Meir EG, Vaubel R, Wade T, Walenkamp AM, Watts C, Weiss T, Weller M, Wesseling P, Westcott K, Westerman B, Ye GY, Yung WKA; GLASS Consortium; Varn FS, Verhaak RG.
Chowdhury T, et al. Among authors: moon he.
bioRxiv [Preprint]. 2025 Jul 15:2025.07.11.664189. doi: 10.1101/2025.07.11.664189.
bioRxiv. 2025.
PMID: 40791422
Free PMC article.
Preprint.